Ea Series Trust Exact Sciences Corp Transaction History
Ea Series Trust
- $2.84 Trillion
- Q2 2023
A detailed history of Ea Series Trust transactions in Exact Sciences Corp stock. As of the latest transaction made, Ea Series Trust holds 9,738 shares of EXAS stock, worth $495,956. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,738Holding current value
$495,956% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
666Shares Held
162MCall Options Held
2.32MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA17.8MShares$905 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$807 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$730 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$615 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$340 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.01B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...